MedPath

Hydrochlorothiazide

HYDROCHLOROTHIAZIDE TABLETS USP

Approved
Approval ID

9cbdc7a7-2e87-4ba0-b5e5-70e15caae63d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 27, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydrochlorothiazide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42254-055
Application NumberANDA040702
Product Classification
M
Marketing Category
C73584
G
Generic Name
Hydrochlorothiazide
Product Specifications
Route of AdministrationORAL
Effective DateApril 8, 2009
FDA Product Classification

INGREDIENTS (7)

STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
HydrochlorothiazideActive
Quantity: 25 mg in 1 1
Code: 0J48LPH2TH
Classification: ACTIB
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hydrochlorothiazide - FDA Drug Approval Details